Contact us
Young GI
Patients
Industry
Press
My Connect
Create myUEG account
About
To landing page
Who we are
Boards, Committees & Groups
Governance
Headquarters Management
History
What we do
Strategic Drivers
Year in Review
Our Members
Specialist Member Societies
National Member Societies
myUEG Community
myUEG Associates
My Connect
Women in GI
Young GIs
Researchers
Event Calendar
Week
To landing page
Programme
Postgraduate Teaching
Industry
Supporters
CME Accreditation
Congress Resources
UEG Week on-demand
Future UEG Weeks
Education
To landing page
Online Education
Online Courses
Webinars
Career Development
Face-to-face Education
Summer School
Masterclass
Clinical Visiting Fellowships
Education Resources
Mistakes in...
UEG Talks Podcast
Image Hub
CME in Europe
Event Endorsement
Supporters
Research
To landing page
Support
Horizon Europe Support
Start-up Grant
Research Prize
Research Fellowship
Research Webinars
Research Projects
HoloSurge
Position Papers
White Book 2
Main Results
Full Reports
Materials and Presentations
Quality of Care
To landing page
Search Guidelines
Standards & Guidelines Repository
Non-English Guidelines
GI Guidelines App
Develop & Implement
How to develop guidelines
Funding for guideline updates
Guideline Endorsement
Guideline Webinars
Projects
Quality of Care Initiatives
Quality Standards
Public Affairs
To landing page
Advocacy
Core Positions
Stakeholder Collaboration
White Book 2
Position Papers
MEP Digestive Health Group
Our Supporters
#EUNewsline →
EU Elections 2024
Publications
To landing page
Publications
Congress Publications
Research Publications
Public Affairs Publications
Education Publications
UEG Publications
UEG Journal →
UEG Journal Podcast
White Book 2
Opportunities
To landing page
Congress Opportunities
Top Abstract Prizes
National Scholar Award
Travel Grants
International Scholarship Awards
Research Funding
Research Prize
Research Fellowship
Horizon Europe Support
Start-up Grant
Activities Funding
Recognition of Achievements
Lifetime Achievement Award
Journal Best Paper Award
Activities Endorsement
Professional Advancement
Rising Star Awards
Clinical Visiting Fellowships
Open Positions
Talent Pool
Library
To landing page
Congress Resources
UEG Week on-demand
Abstracts
Posters
Guideline Resources
Education Resources
Image Hub
Webinars
Mistakes in... articles
Contact us
Young GI
Patients
Industry
Press
Session
NASH and diagnostics (Posters)
MYOSTEATOSIS AND FRAILTY FACTORS ASSOCIATED WITH THE OCCURRENCE OF COMPLICATIONS IN CIRRHOTIC PATIENTS: MYOFACC STUDY
MICRORNAS, SEROLOGICAL MARKERS OF LIVER FIBROSIS, HEMATOLOGICAL SCALES, CYTOKERATINS AND GOLGI PROTEIN 73 - A NEW POTENTIAL COMBINATION FOR THE DIAGNOSTICS OF ALCOHOL-RELATED LIVER CIRRHOSIS
EXTRACELLULAR VESICLES FROM TGR5-ACTIVATED ADIPOCYTES ELICIT ANTI-INFLAMMATORY EFFECTS UPON HEPATOCYTES EXPOSED TO NAFLD-ASSOCIATED PATHOGENIC STIMULI
FATTY LIVER QUANTIFICATION USING ULTRASOUND DERIVED FAT FRACTION (UDFF) AS COMPARED TO CONTROLLED ATTENUATION PARAMETER (CAP) IN A MIXED COHORT OF PATIENTS
HOW MANY AUTO PSWE AND ULTRASOUND DERIVED FAT FRACTION (UDFF) ACQUISITIONS SHOULD WE MAKE IN ORDER TO OBTAIN THE BEST RESULT?
ASSESSMENT OF LIVER FIBROSIS BY ACOUSTIC RADIATION FORCE IMPULSE IMAGING COMBINED WITH RESULTS OF MINI-LAPAROSCOPY AND HISTOLOGY EVALUATION: A SINGLE-CENTER TRIAL
THE UTILITY OF PENTRAXIN 3 AND PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA AS NON-INVASIVE BIOMARKERS FOR PREDICTION OF CARDIOVASCULAR RISK IN MAFLD PATIENTS
QUALITY CRITERIA IN DETECTING LIVER FIBROSIS BY 2D SW ELASTOGRAPHY. DOES THE ETIOLOGY OF LIVER DISEASE MATTER?
THE EFFICACY OF QUERCETIN ADMINISTRATION IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS
THE EFFECT OF ROUX-EN-Y GASTRIC BYPASS ON NON-ALCOHOLIC FATTY LIVER DISEASE FIBROSIS ASSESSED BY FIB-4 AND NFS SCORES - AN 11.6-YEAR FOLLOW-UP-STUDY
THE EFFECT OF ROUX-EN-Y GASTRIC BYPASS ON NON-ALCOHOLIC FATTY LIVER DISEASE FIBROSIS ASSESSED BY FIB-4 AND NFS SCORES - AN 11.6-YEAR FOLLOW-UP-STUDY
NASH and diagnostics (Posters)
et al.
THE EFFICACY OF QUERCETIN ADMINISTRATION IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS
NASH and diagnostics (Posters)
et al.
QUALITY CRITERIA IN DETECTING LIVER FIBROSIS BY 2D SW ELASTOGRAPHY. DOES THE ETIOLOGY OF LIVER DISEASE MATTER?
NASH and diagnostics (Posters)
et al.
THE UTILITY OF PENTRAXIN 3 AND PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA AS NON-INVASIVE BIOMARKERS FOR PREDICTION OF CARDIOVASCULAR RISK IN MAFLD PATIENTS
NASH and diagnostics (Posters)
et al.
ASSESSMENT OF LIVER FIBROSIS BY ACOUSTIC RADIATION FORCE IMPULSE IMAGING COMBINED WITH RESULTS OF MINI-LAPAROSCOPY AND HISTOLOGY EVALUATION: A SINGLE-CENTER TRIAL
NASH and diagnostics (Posters)
et al.
HOW MANY AUTO PSWE AND ULTRASOUND DERIVED FAT FRACTION (UDFF) ACQUISITIONS SHOULD WE MAKE IN ORDER TO OBTAIN THE BEST RESULT?
NASH and diagnostics (Posters)
et al.
FATTY LIVER QUANTIFICATION USING ULTRASOUND DERIVED FAT FRACTION (UDFF) AS COMPARED TO CONTROLLED ATTENUATION PARAMETER (CAP) IN A MIXED COHORT OF PATIENTS
NASH and diagnostics (Posters)
et al.
EXTRACELLULAR VESICLES FROM TGR5-ACTIVATED ADIPOCYTES ELICIT ANTI-INFLAMMATORY EFFECTS UPON HEPATOCYTES EXPOSED TO NAFLD-ASSOCIATED PATHOGENIC STIMULI
NASH and diagnostics (Posters)
et al.
MICRORNAS, SEROLOGICAL MARKERS OF LIVER FIBROSIS, HEMATOLOGICAL SCALES, CYTOKERATINS AND GOLGI PROTEIN 73 - A NEW POTENTIAL COMBINATION FOR THE DIAGNOSTICS OF ALCOHOL-RELATED LIVER CIRRHOSIS
NASH and diagnostics (Posters)
et al.
MYOSTEATOSIS AND FRAILTY FACTORS ASSOCIATED WITH THE OCCURRENCE OF COMPLICATIONS IN CIRRHOTIC PATIENTS: MYOFACC STUDY
NASH and diagnostics (Posters)
et al.
Item 1 - 20 / 20
1
Chat with us
, powered by
LiveChat